These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2860611)

  • 1. Lower CSF level of dynorphin(1-8) immunoreactivity in schizophrenic patients.
    Zhang AZ; Zhou GZ; Xi GF; Gu NF; Xia ZY; Yao JL; Chang JK; Webber R; Potkin S
    Neuropeptides; 1985 Feb; 5(4-6):553-6. PubMed ID: 2860611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynorphin A and substance P in the cerebrospinal fluid of schizophrenic patients.
    Heikkilä L; Rimón R; Terenius L
    Psychiatry Res; 1990 Dec; 34(3):229-36. PubMed ID: 1706098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of CSF dynorphin A 1-8 immunoreactivity in anorexia nervosa and normal-weight bulimia.
    Lesem MD; Berrettini WH; Kaye WH; Jimerson DC
    Biol Psychiatry; 1991 Feb; 29(3):244-52. PubMed ID: 1673064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of immunoreactive dynorphin in human cerebrospinal fluid.
    Tozawa F; Suda T; Tachibana S; Tomori N; Demura H; Shizume K
    Life Sci; 1984 Oct; 35(16):1633-7. PubMed ID: 6148680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of Ligusticum wallichii on the plasma and CSF levels of dynorphin A1-13 in rabbits under acute experimental cerebral ischemia].
    Liu Z; Shi Y
    Zhong Xi Yi Jie He Za Zhi; 1990 Mar; 10(3):160-1, 163, 133. PubMed ID: 1974173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated CSF dynorphin A [1-8] in Tourette's syndrome.
    Leckman JF; Riddle MA; Berrettini WH; Anderson GM; Hardin M; Chappell P; Bissette G; Nemeroff CB; Goodman WK; Cohen DJ
    Life Sci; 1988; 43(24):2015-23. PubMed ID: 2463450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of dynorphin A(1-13).
    Brugos B; Hochhaus G
    Pharmazie; 2004 May; 59(5):339-43. PubMed ID: 15212298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced cerebrospinal fluid dynorphin A1-8 in Alzheimer's disease.
    Sunderland T; Berrettini WH; Molchan SE; Lawlor BA; Martinez RA; Vitiello B; Tariot PN; Cohen RM
    Biol Psychiatry; 1991 Jul; 30(1):81-7. PubMed ID: 1716470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of substance P-like peptides in the CSF of psychiatric patients.
    Rimón R; Le Grevés P; Nyberg F; Heikkilä L; Salmela L; Terenius L
    Biol Psychiatry; 1984 Apr; 19(4):509-16. PubMed ID: 6203562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enkephalin, dynorphin and substance P in postmortem substantia nigra from normals and schizophrenic patients.
    Iadarola MJ; Ofri D; Kleinman JE
    Life Sci; 1991; 48(20):1919-30. PubMed ID: 1708847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF opioids in panic disorder.
    Brady KT; Lydiard RB; Ballenger JC; Shook J; Laraia M; Fossey M
    Biol Psychiatry; 1991 Sep; 30(5):512-4. PubMed ID: 1681945
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebrospinal fluid dynorphin A[1-8] and beta-endorphin levels in Tourette's syndrome are unaltered.
    van Wattum PJ; Anderson GM; Chappell PB; Goodman WK; Riddle MA; Leckman JF
    Biol Psychiatry; 1999 Jun; 45(11):1527-8. PubMed ID: 10356639
    [No Abstract]   [Full Text] [Related]  

  • 13. An inhibitor of endopeptidase-24.15 blocks the degradation of intraventricularly administered dynorphins.
    Molineaux CJ; Ayala JM
    J Neurochem; 1990 Aug; 55(2):611-8. PubMed ID: 1973455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced CSF neurotensin concentration in drug-free schizophrenic patients.
    Lindström LH; Widerlöv E; Bisette G; Nemeroff C
    Schizophr Res; 1988; 1(1):55-9. PubMed ID: 3154507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of dynorphin A1-13 in human CSF.
    Müller S; Grundy BL; Hochhaus G
    Neurochem Res; 1996 Oct; 21(10):1213-9. PubMed ID: 8923483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynorphin A immunoreactivity in human cerebrospinal fluid.
    Nyberg F; Nylander I
    Regul Pept; 1987 Mar; 17(3):159-66. PubMed ID: 2884698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuropeptide FF analogue, 1DMe, reduces in vivo dynorphin release from the rat spinal cord.
    Ballet S; Braz J; Mauborgne A; Bourgoin S; Zajac JM; Hamon M; Cesselin F
    J Neurochem; 2002 May; 81(3):659-62. PubMed ID: 12065675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF levels of receptor-active endorphins in schizophrenic patients: correlations with symptomatology and monoamine metabolites.
    Lindström LH; Besev G; Gunne LM; Terenius L
    Psychiatry Res; 1986 Oct; 19(2):93-100. PubMed ID: 2431427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome.
    Nemeroff CB; Bissette G; Widerlov E; Beckmann H; Gerner R; Manberg PJ; Lindstrom L; Prange AJ; Gattaz WF
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):16-20. PubMed ID: 2577718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of immunoreactive dynorphin B in discrete areas of the rat brain and spinal cord.
    Zamir N; Palkovits M; Weber E; Brownstein MJ
    Brain Res; 1984 May; 300(1):121-7. PubMed ID: 6733459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.